Skip to main content
Top
Published in: BMC Urology 1/2020

Open Access 01-12-2020 | Research article

Survival rate of patients with bladder cancer and its related factors in Kurdistan Province (2013–2018): a population-based study

Authors: Mozhdeh Amiri, Sofimajidpour Heshmatollah, Nader Esmaeilnasab, Jamshid Khoubi, Ebrahim Ghaderi, Daem Roshani

Published in: BMC Urology | Issue 1/2020

Login to get access

Abstract

Background

Bladder cancer is one of the most common urinary tract cancers. This study aims to estimate the survival rate of patients with bladder cancer according to the Cox proportional hazards model based on some key relevant variables.

Methods

In this retrospective population-based cohort study that explores the survival of patients with bladder cancer and its related factors, we first collected demographic information and medical records of 321 patients with bladder cancer through in-person and telephone interviews. Then, in the analysis phase, Kaplan–Meier method and log-rank test were used to draw the survival curve, compare the groups, and explore the effect of risk factors on the patient survival rate using Cox proportional hazards model.

Results

The median survival rate of patients was 63.2 (54.7–72) months and one, three and five-year survival rates were 87%, 68% and 54%, respectively. The results of multiple analyses using Cox's proportional hazards model revealed that variables of sex (male gender) (HR = 11.8, 95% CI: 0.4–100.7), more than 65 year of age (HR = 4.1, 95% CI: 0.4–11), occupation, income level, (HR = 0.4, 95% CI: 0.2–0.8), well differentiated tumor grade (HR = 3.2, 95% CI: 1.7–6) and disease stage influenced the survival rate of patients (p < 0.05).

Conclusion

The survival rate of patients with bladder cancer in Kurdistan province is relatively low. Given the impact of the disease stage on the survival rate, adequate access to appropriate diagnostic and treatment services as well as planning for screening and early diagnosis, especially in men, can increase the survival rate of patients.
Literature
1.
go back to reference Koosha A, Farahbakhsh M, Hakimi S, Abdolahi L, Golzari M, Farshad MS. Epidemiologic assessment of cancer disease in East Azerbaijan 2007. Med J Tabriz Univ Med Sci Health Serv. 2010;32(4):74–9. Koosha A, Farahbakhsh M, Hakimi S, Abdolahi L, Golzari M, Farshad MS. Epidemiologic assessment of cancer disease in East Azerbaijan 2007. Med J Tabriz Univ Med Sci Health Serv. 2010;32(4):74–9.
2.
go back to reference Ploeg M, Aben KK, Kiemeney LA. The present and future burden of urinary bladder cancer in the world. World J Urol. 2009;27(3):289–93.CrossRef Ploeg M, Aben KK, Kiemeney LA. The present and future burden of urinary bladder cancer in the world. World J Urol. 2009;27(3):289–93.CrossRef
3.
go back to reference Salehi A, Khezri AA, Malekmakan L, Aminsharifi A. Epidemiologic status of bladder cancer in Shiraz, southern Iran. Asian Pac J Cancer Prev. 2011;12(5):1323–7.PubMed Salehi A, Khezri AA, Malekmakan L, Aminsharifi A. Epidemiologic status of bladder cancer in Shiraz, southern Iran. Asian Pac J Cancer Prev. 2011;12(5):1323–7.PubMed
4.
go back to reference Mahdavi S, Amoori N, Salehiniya H, Almasi Z, Enayatrad M. Trend of bladder cancer mortality in Iran (2006 to 2010). Int J Epidemiol Res. 2015;2(4):184–9. Mahdavi S, Amoori N, Salehiniya H, Almasi Z, Enayatrad M. Trend of bladder cancer mortality in Iran (2006 to 2010). Int J Epidemiol Res. 2015;2(4):184–9.
5.
go back to reference Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA: Cancer J Clin. 2011;61(2):69–90. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA: Cancer J Clin. 2011;61(2):69–90.
6.
go back to reference Miller KD, Siegel RL, Lin CC, Mariotto AB, Kramer JL, Rowland JH, Stein KD, Alteri R, Jemal A. Cancer treatment and survivorship statistics, 2016. CA: Cancer J Clin. 2016;66(4):271–89. Miller KD, Siegel RL, Lin CC, Mariotto AB, Kramer JL, Rowland JH, Stein KD, Alteri R, Jemal A. Cancer treatment and survivorship statistics, 2016. CA: Cancer J Clin. 2016;66(4):271–89.
7.
go back to reference Fajkovic H, Halpern JA, Cha EK, Bahadori A, Chromecki TF, Karakiewicz PI, Breinl E, Merseburger AS, Shariat SF. Impact of gender on bladder cancer incidence, staging, and prognosis. World J Urol. 2011;29(4):457–63.CrossRef Fajkovic H, Halpern JA, Cha EK, Bahadori A, Chromecki TF, Karakiewicz PI, Breinl E, Merseburger AS, Shariat SF. Impact of gender on bladder cancer incidence, staging, and prognosis. World J Urol. 2011;29(4):457–63.CrossRef
8.
go back to reference Mungan NA, Aben KK, Schoenberg MP, Visser O, Coebergh JW, Witjes JA, Kiemeney LA. Gender differences in stage-adjusted bladder cancer survival. Urology. 2000;55(6):876–80.CrossRef Mungan NA, Aben KK, Schoenberg MP, Visser O, Coebergh JW, Witjes JA, Kiemeney LA. Gender differences in stage-adjusted bladder cancer survival. Urology. 2000;55(6):876–80.CrossRef
9.
go back to reference Kiemeney L, Mungan N, Aben K, Schoenberg M, Visser O, Coebergh J, et al. Gender differences in stage-adjusted bladder cancer survival. 2000;151(11):S68. Kiemeney L, Mungan N, Aben K, Schoenberg M, Visser O, Coebergh J, et al. Gender differences in stage-adjusted bladder cancer survival. 2000;151(11):S68.
10.
go back to reference Najari BB, Rink M, Li PS, Karakiewicz PI, Scherr DS, Shabsigh R, Meryn S, Schlegel PN, Shariat SF. Sex disparities in cancer mortality: the risks of being a man in the United States. J Urol. 2013;189(4):1470–4.CrossRef Najari BB, Rink M, Li PS, Karakiewicz PI, Scherr DS, Shabsigh R, Meryn S, Schlegel PN, Shariat SF. Sex disparities in cancer mortality: the risks of being a man in the United States. J Urol. 2013;189(4):1470–4.CrossRef
11.
go back to reference Scosyrev E, Noyes K, Feng C, Messing E. Sex and racial differences in bladder cancer presentation and mortality in the US. Cancer. 2009;115(1):68–74.CrossRef Scosyrev E, Noyes K, Feng C, Messing E. Sex and racial differences in bladder cancer presentation and mortality in the US. Cancer. 2009;115(1):68–74.CrossRef
12.
go back to reference Mohaghegh F, Hamta A. The study of cancer incidence and cancer registration in Markazi province between 2001–2006 and comparison with national statistics. Iran. J Arak Univ Med Sci. 2008;11(2):84–93. Mohaghegh F, Hamta A. The study of cancer incidence and cancer registration in Markazi province between 2001–2006 and comparison with national statistics. Iran. J Arak Univ Med Sci. 2008;11(2):84–93.
13.
go back to reference Ahmad E, Ghasem KO, Dastoori P. Recurrence rate and prognostic factors of superficial bladder cancer in shiraz shahid faghihi hospital during the years 1998–2001. Ahmad E, Ghasem KO, Dastoori P. Recurrence rate and prognostic factors of superficial bladder cancer in shiraz shahid faghihi hospital during the years 1998–2001.
14.
go back to reference Whelan P. Survival from bladder cancer in England and Wales up to 2001. British J Cancer. 2008;99(Suppl 1):S90.CrossRef Whelan P. Survival from bladder cancer in England and Wales up to 2001. British J Cancer. 2008;99(Suppl 1):S90.CrossRef
15.
go back to reference Brookfield KF, Cheung MC, Gomez C, Yang R, Nieder AM, Lee DJ, Koniaris LG. Survival disparities among African American women with invasive bladder cancer in Florida. Cancer: Interdiscip Int J Am Cancer Soc. 2009;115(18):4196–209.CrossRef Brookfield KF, Cheung MC, Gomez C, Yang R, Nieder AM, Lee DJ, Koniaris LG. Survival disparities among African American women with invasive bladder cancer in Florida. Cancer: Interdiscip Int J Am Cancer Soc. 2009;115(18):4196–209.CrossRef
16.
go back to reference Nourafkan Z, Yavari P, Roshandel GH, Khalili D, Zayeri F. Estimation of survival rate of esophageal cancer and some of its determinants in Golestan province, north of Iran. Iran J Epidemiol. 2013;9(1):11–8. Nourafkan Z, Yavari P, Roshandel GH, Khalili D, Zayeri F. Estimation of survival rate of esophageal cancer and some of its determinants in Golestan province, north of Iran. Iran J Epidemiol. 2013;9(1):11–8.
17.
go back to reference Farahmand M, Khadem AF, Medhati M, Shokrpour N, Joulaei H, Mehrbani D. Trend of bladder cancer in Fars province, southern Iran, 2002–2006. Farahmand M, Khadem AF, Medhati M, Shokrpour N, Joulaei H, Mehrbani D. Trend of bladder cancer in Fars province, southern Iran, 2002–2006.
18.
go back to reference Toutounchi M, Mazdak H, Najafipour S, Soleymani B. Bladder cancer risk factors among Isfahan population: a case-control study. Toutounchi M, Mazdak H, Najafipour S, Soleymani B. Bladder cancer risk factors among Isfahan population: a case-control study.
19.
go back to reference Mohammadbeigi A, Rezaeian Zadeh A. Application of life table in survival analysis of patients with bladder cancer. Zahedan J Res Med Sci. 2011;13(3). Mohammadbeigi A, Rezaeian Zadeh A. Application of life table in survival analysis of patients with bladder cancer. Zahedan J Res Med Sci. 2011;13(3).
21.
go back to reference Fischer-Valuck BW, Rao YJ, Rudra S, Przybysz D, Germino E, Samson P, Baumann BC, Gay H, Michalski J. Treatment patterns and overall survival outcomes of octogenarians with muscle invasive cancer of the bladder: an analysis of the national cancer database. J Urol. 2018;199(2):416–23.CrossRef Fischer-Valuck BW, Rao YJ, Rudra S, Przybysz D, Germino E, Samson P, Baumann BC, Gay H, Michalski J. Treatment patterns and overall survival outcomes of octogenarians with muscle invasive cancer of the bladder: an analysis of the national cancer database. J Urol. 2018;199(2):416–23.CrossRef
22.
go back to reference Cumberbatch MG, Jubber I, Black PC, Esperto F, Figueroa JD, Kamat AM, Kiemeney L, Lotan Y, Pang K, Silverman DT, Znaor A. Epidemiology of bladder cancer: a systematic review and contemporary update of risk factors in 2018. Eur Urol. 2018;74(6):784–95.CrossRef Cumberbatch MG, Jubber I, Black PC, Esperto F, Figueroa JD, Kamat AM, Kiemeney L, Lotan Y, Pang K, Silverman DT, Znaor A. Epidemiology of bladder cancer: a systematic review and contemporary update of risk factors in 2018. Eur Urol. 2018;74(6):784–95.CrossRef
23.
go back to reference Lara J, Brunson A, Keegan TH, Malogolowkin M, Pan CX, Yap S, deVere White R. Determinants of survival for adolescents and young adults with urothelial bladder cancer: results from the california cancer registry. J Urol. 2016;196(5):1378–82.CrossRef Lara J, Brunson A, Keegan TH, Malogolowkin M, Pan CX, Yap S, deVere White R. Determinants of survival for adolescents and young adults with urothelial bladder cancer: results from the california cancer registry. J Urol. 2016;196(5):1378–82.CrossRef
24.
go back to reference Williams SB, Huo J, Dafashy TJ, Ghaffary CK, Baillargeon JG, Morales EE, Kim SP, Kuo YF, Orihuela E, Tyler DS, Freedland SJ. Survival differences among patients with bladder cancer according to sex: critical evaluation of radical cystectomy use and delay to treatment. In: Urologic oncology: seminars and original investigations, vol. 35, no. 10. Elsevier; 2017. Williams SB, Huo J, Dafashy TJ, Ghaffary CK, Baillargeon JG, Morales EE, Kim SP, Kuo YF, Orihuela E, Tyler DS, Freedland SJ. Survival differences among patients with bladder cancer according to sex: critical evaluation of radical cystectomy use and delay to treatment. In: Urologic oncology: seminars and original investigations, vol. 35, no. 10. Elsevier; 2017.
25.
go back to reference Chen W, Zheng R, Baade PD, Zhang S, Zeng H, Bray F, Jemal A, Yu XQ, He J. Cancer statistics in China, 2015. CA: Cancer J Clin. 2016;66(2):115–32. Chen W, Zheng R, Baade PD, Zhang S, Zeng H, Bray F, Jemal A, Yu XQ, He J. Cancer statistics in China, 2015. CA: Cancer J Clin. 2016;66(2):115–32.
26.
go back to reference Khoubi J, Pourabdian S, Mohebbi I, Tajvidi M, Zaroorian O, Giahi O. Association between the high risk occupations and bladder cancer in Iran: a case-control study. Int J Occup Med Environ Health. 2013;26(2):205–13.CrossRef Khoubi J, Pourabdian S, Mohebbi I, Tajvidi M, Zaroorian O, Giahi O. Association between the high risk occupations and bladder cancer in Iran: a case-control study. Int J Occup Med Environ Health. 2013;26(2):205–13.CrossRef
27.
go back to reference Korpics MC, Block AM, Martin B, Hentz C, Gaynor ER, Henry E, Harkenrider MM, Solanki AA. Concurrent chemotherapy is associated with improved survival in elderly patients with bladder cancer undergoing radiotherapy. Cancer. 2017;123(18):3524–31.CrossRef Korpics MC, Block AM, Martin B, Hentz C, Gaynor ER, Henry E, Harkenrider MM, Solanki AA. Concurrent chemotherapy is associated with improved survival in elderly patients with bladder cancer undergoing radiotherapy. Cancer. 2017;123(18):3524–31.CrossRef
28.
go back to reference Klapheke A, Yap SA, Pan K, Cress RD. Sociodemographic disparities in chemotherapy treatment and impact on survival among patients with metastatic bladder cancer. In: Urologic oncology: seminars and original investigations, vol. 36, no. 6. Elsevier; 2018. Klapheke A, Yap SA, Pan K, Cress RD. Sociodemographic disparities in chemotherapy treatment and impact on survival among patients with metastatic bladder cancer. In: Urologic oncology: seminars and original investigations, vol. 36, no. 6. Elsevier; 2018.
Metadata
Title
Survival rate of patients with bladder cancer and its related factors in Kurdistan Province (2013–2018): a population-based study
Authors
Mozhdeh Amiri
Sofimajidpour Heshmatollah
Nader Esmaeilnasab
Jamshid Khoubi
Ebrahim Ghaderi
Daem Roshani
Publication date
01-12-2020
Publisher
BioMed Central
Published in
BMC Urology / Issue 1/2020
Electronic ISSN: 1471-2490
DOI
https://doi.org/10.1186/s12894-020-00769-1

Other articles of this Issue 1/2020

BMC Urology 1/2020 Go to the issue